calcitriol fairmed 0.25 mcg capsule molli
calcitriol fairmed 0.5 mcg weichkapseln
calcitriol fairmed 0.5 mcg capsule molli
dovobet ointment pommade
leo pharma inc - calcipotriol; bétaméthasone (dipropionate de bétaméthasone) - pommade - 50mcg; 0.5mg - calcipotriol 50mcg; bétaméthasone (dipropionate de bétaméthasone) 0.5mg - anti-inflammatory agents
crysvita
kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - médicaments pour le traitement des maladies osseuses - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
calcium-phosphatbinder bichsel capsules
grosse apotheke dr. g. bichsel ag - calcii carbonas - capsules - le calcium carbonas 500 mg, excipiens pro de la capsule. - phosphate de - synthetika
calcium-phosphatbinder bichsel 500 mg comprimés
grosse apotheke dr. g. bichsel ag - calcii carbonas - comprimés - calcii carbonas (500 mg, excipiens pro pilote. - phosphate de - synthetika
calcium-phosphatbinder bichsel 1000 mg comprimés
grosse apotheke dr. g. bichsel ag - calcii carbonas - comprimés - calcii carbonas, 1000 mg, excipiens pro pilote. - phosphate de - synthetika
vitamin d3 streuli prophylax solution buvable
streuli pharma ag - cholecalciferolum - solution buvable - cholecalciferolum 4000 u.i., triglycerida media ad solutionem pro 1 ml. - la vitamine d-préparation - synthetika
vitamin d3 streuli zur therapie solution buvable
streuli pharma ag - cholecalciferolum - solution buvable - cholecalciferolum 4000 u.i., triglycerida media ad solutionem pro 1 ml. - la vitamine d-préparation - synthetika